EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

J. Ribamar Costa Jr1, MD; Alexandre Abizaid1*, MD, PhD; Fausto Feres1, MD, PhD; Ricardo Costa1, MD; Ana Cristina Seixas1, MD; Felipe Maia1, MD; Andrea Abizaid1, MD, PhD; Luis Fernando Tanajura1, MD, PhD; Rodolfo Staico1, MD; Dimytri Siqueira1, MD; Lynn Meredith2, Vinayak Bhat, PhD; John Yan2; John Ormiston3, MD; Amanda G.M.R. Sousa1, MD, PhD; Peter Fitzgerald4, MD, PhD; J. Eduardo Sousa1, MD, PhD